Cannabinoid Encyclopedia

Cannabinoid guide

What is Virodhamine?

A clear guide to Virodhamine: what it is, what researchers have studied, how strong the evidence is, and what to know about safety.

Updated July 2026 11 research sources Mostly early-stage research

The short answer

Virodhamine, in simple terms

Virodhamine is a cannabinoid-related compound represented in the scientific literature. Researchers study it for possible effects, safety, and how it works in the body. Most of the current evidence is preclinical or focused on biological mechanisms. The evidence does not turn this into one proven benefit, because studies can use different products, doses, routes, people, and outcomes. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Virodhamine.

Why people look into itSee the main questions before the research details. What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Why people look into Virodhamine

What Virodhamine is commonly talked about for

These cards show the questions most represented in this source set. They are not a list of proven benefits, and the evidence label matters as much as the topic name.

  1. Mostly mechanism-focused

    Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms

    Safety research asks how Virodhamine, its dose, route, formulation, and other medications may change risk. The available evidence may not answer the safety question for every product or person. 2

    See research areas

Bottom line: Start with the exact question you care about, then check the study type, product, dose, and outcome before treating a research signal as a real-world effect.

Key takeaways

What to know first

  1. 1

    Research on Virodhamine covers Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What has Virodhamine been studied for?

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms

Researchers have examined Virodhamine in connection with Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. The studies may differ in compound, formulation, dose, route, population, and outcome. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

5 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

3 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on Virodhamine is not one kind of study. This source set includes 5 cell or laboratory studies, 3 animal studies, and 3 narrative or expert reviews. 3

The recorded populations or models include people or patients (5 sources), cells or tissue models (3 sources), and animal models (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms (11 sources). Closely related outcome names can still describe different measurements. 5

The Virodhamine source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

animal study

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

On this page, this source examines Virodhamine and virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 1

Study type
animal study
Population or model
people or patients
Outcome focus
virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

Endocannabinoids and Their Pharmacological Actions.

On this page, this source examines Virodhamine and virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 2

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

GPR55: a new member of the cannabinoid receptor clan?

On this page, this source examines Virodhamine and virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 3

Study type
narrative or expert review
Population or model
animal models
Outcome focus
virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

The role of the CB1 receptor in the regulation of sleep.

On this page, this source examines Virodhamine and virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 4

Study type
narrative or expert review
Outcome focus
virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

animal study

Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.

On this page, this source examines Virodhamine and virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 5

Study type
animal study
Population or model
animal models
Outcome focus
virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on Virodhamine should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What is Virodhamine?

Virodhamine is a cannabinoid-related compound studied across Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. This page separates those research questions so they are not mistaken for one broad claim. 7

What has Virodhamine been studied for?

The current source set includes Virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. Each area may use different doses, products, routes, populations, and outcome measures. 8

How strong is the research on Virodhamine?

Most of the current evidence is preclinical or focused on biological mechanisms. 9

Is Virodhamine safe?

Safety cannot be answered for Virodhamine without context. Dose, route, formulation, medications, and the person using it can all change risk. 10

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. animal study; mechanism-focused research PubMed 12023533 DOI 10.1124/jpet.301.3.1020
  2. 2
    Endocannabinoids and Their Pharmacological Actions. narrative or expert review; evidence still limited PubMed 26408156 DOI 10.1007/978-3-319-20825-1_1
  3. 3
    GPR55: a new member of the cannabinoid receptor clan? narrative or expert review; evidence still limited PubMed 17876300 DOI 10.1038/sj.bjp.0707464
  4. 4
    The role of the CB1 receptor in the regulation of sleep. narrative or expert review; evidence still limited PubMed 18514375 DOI 10.1016/j.pnpbp.2008.04.008
  5. 5
    Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. animal study; mechanism-focused research PubMed 15233865 DOI 10.1211/0022357023682
  6. 6
    Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. animal study; mechanism-focused research PubMed 18806815 DOI 10.1038/bjp.2008.371
  7. 7
    (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. cell or laboratory study; mechanism-focused research PubMed 19255745 DOI 10.1007/s00210-009-0406-z
  8. 8
    Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B. cell or laboratory study; mechanism-focused research PubMed 29958841 DOI 10.1016/j.bcp.2018.06.024
  9. 9
    Mechanism of platelet activation induced by endocannabinoids in blood and plasma. cell or laboratory study; mechanism-focused research PubMed 23789792 DOI 10.3109/09537104.2013.803530
  10. 10
    The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. cell or laboratory study; mechanism-focused research PubMed 22454039 DOI 10.1007/s11481-012-9351-6
  11. 11
    Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria. cell or laboratory study; mechanism-focused research PubMed 32696508 DOI 10.1002/jcp.29949
See all 11 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Endocannabinoids and Their Pharmacological Actions. narrative or expert review; evidence still limited / 1 linked research note PubMed 26408156
  2. GPR55: a new member of the cannabinoid receptor clan? narrative or expert review; evidence still limited / 1 linked research note PubMed 17876300
  3. The role of the CB1 receptor in the regulation of sleep. narrative or expert review; evidence still limited / 1 linked research note PubMed 18514375
  4. Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. animal study; mechanism-focused research / 1 linked research note PubMed 18806815
  5. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. animal study; mechanism-focused research / 1 linked research note PubMed 12023533
  6. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 22454039
  7. Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 32696508
  8. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. animal study; mechanism-focused research / 1 linked research note PubMed 15233865
  9. Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 29958841
  10. Mechanism of platelet activation induced by endocannabinoids in blood and plasma. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 23789792
  11. (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 19255745